Literature DB >> 33748545

The Operation of Canada's Only Virtually Operated Radiation Oncology Service During the COVID-19 Pandemic.

Claire Romani1, Michael Conlon2, Mike Oliver2,3, Konrad Leszczynski2,3, Michele Hunter2,4, Kevin Lam2, Silvana Spadafora3,4, Andrew Pearce2,3,4.   

Abstract

PURPOSE: Our institution operates a remote radiation oncology service in Northern Ontario, Canada. Since the start of the coronavirus disease 2019 pandemic, this center has operated without radiation oncologists on site owing to safety precautions, and this study seeks to understand the effect of this shift. METHODS AND MATERIALS: Departmental level data reports were used to investigate differences in metrics between April to May of 2019 and April to May 2020. These metrics include the total number of referrals received, average wait time from referral to consult, the number of cases that underwent peer review before beginning treatment, the total number of fractions given over each period, patient-reported outcomes, and patient satisfaction. We also examined the importance of physical examinations and the use of SABR treatment.
RESULTS: There was an observed decrease in the number of referrals received, total number of fractions administered, and number of patients providing patient-reported outcomes. We observed no change in patient wait times, cases undergoing peer review before commencing treatment, or overall patient satisfaction. Challenges were identified in the collection of patient- reported outcomes and the conduction of physical examinations.
CONCLUSIONS: This paper provides proof of concept that a radiation clinic can function entirely virtually in the short term without sacrificing patient satisfaction, efficiency, or safety.
© 2020 The Authors.

Entities:  

Year:  2020        PMID: 33748545      PMCID: PMC7966849          DOI: 10.1016/j.adro.2020.100634

Source DB:  PubMed          Journal:  Adv Radiat Oncol        ISSN: 2452-1094


  8 in total

1.  The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.

Authors:  A Sahgal; D Roberge; D Schellenberg; T G Purdie; A Swaminath; J Pantarotto; E Filion; Z Gabos; J Butler; D Letourneau; G L Masucci; L Mulroy; A Bezjak; L A Dawson; M Parliament
Journal:  Clin Oncol (R Coll Radiol)       Date:  2012-05-24       Impact factor: 4.126

2.  Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis.

Authors:  Ronald Chow; Peter Hoskin; Steven E Schild; Srinivas Raman; James Im; Daniel Zhang; Stephanie Chan; Nicholas Chiu; Leonard Chiu; Henry Lam; Edward Chow; Michael Lock
Journal:  Radiother Oncol       Date:  2019-08-21       Impact factor: 6.280

3.  Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study.

Authors:  B Ciseł; L Pietrzak; W Michalski; L Wyrwicz; A Rutkowski; E Kosakowska; A Cencelewicz; M Spałek; W Polkowski; M Jankiewicz; R Styliński; M Bębenek; B Kapturkiewicz; A Maciejczyk; J Sadowski; J Zygulska; W Zegarski; M Jankowski; M Las-Jankowska; Z Toczko; U Żelazowska-Omiotek; L Kępka; J Socha; E Wasilewska-Tesluk; W Markiewicz; J Kładny; A Majewski; W Kapuściński; R Suwiński; K Bujko
Journal:  Ann Oncol       Date:  2019-08-01       Impact factor: 32.976

4.  ACR-ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy.

Authors:  Samuel T Chao; Luqman K Dad; Laura A Dawson; Neil B Desai; Matthew Pacella; Ramesh Rengan; Ying Xiao; Kamil M Yenice; Seth A Rosenthal; Alan Hartford
Journal:  Am J Clin Oncol       Date:  2020-08       Impact factor: 2.339

5.  Electronic Patient-Reported Outcome Measures in Radiation Oncology: Initial Experience After Workflow Implementation.

Authors:  Franziska Hauth; Verena Bizu; Rehan App; Heinrich Lautenbacher; Alina Tenev; Michael Bitzer; Nisar Peter Malek; Daniel Zips; Cihan Gani
Journal:  JMIR Mhealth Uhealth       Date:  2019-07-24       Impact factor: 4.773

6.  COVID-19: Global radiation oncology's targeted response for pandemic preparedness.

Authors:  Richard Simcock; Toms Vengaloor Thomas; Christopher Estes; Andrea R Filippi; Matthew A Katz; Ian J Pereira; Hina Saeed
Journal:  Clin Transl Radiat Oncol       Date:  2020-03-24

7.  Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study.

Authors:  Pierina Navarria; Federico Pessina; Stefano Tomatis; Riccardo Soffietti; Marco Grimaldi; Egesta Lopci; Arturo Chiti; Antonella Leonetti; Alessandra Casarotti; Marco Rossi; Luca Cozzi; Anna Maria Ascolese; Matteo Simonelli; Simona Marcheselli; Armando Santoro; Elena Clerici; Lorenzo Bello; Marta Scorsetti
Journal:  Oncotarget       Date:  2017-06-28

8.  Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.

Authors:  Adrian Murray Brunt; Joanne S Haviland; Duncan A Wheatley; Mark A Sydenham; Abdulla Alhasso; David J Bloomfield; Charlie Chan; Mark Churn; Susan Cleator; Charlotte E Coles; Andrew Goodman; Adrian Harnett; Penelope Hopwood; Anna M Kirby; Cliona C Kirwan; Carolyn Morris; Zohal Nabi; Elinor Sawyer; Navita Somaiah; Liba Stones; Isabel Syndikus; Judith M Bliss; John R Yarnold
Journal:  Lancet       Date:  2020-04-28       Impact factor: 202.731

  8 in total
  3 in total

Review 1.  Mitigating the Impact of the COVID-19 Pandemic on Adult Cancer Patients through Telehealth Adoption: A Systematic Review.

Authors:  Aileen Murphy; Ann Kirby; Amy Lawlor; Frances J Drummond; Ciara Heavin
Journal:  Sensors (Basel)       Date:  2022-05-09       Impact factor: 3.847

2.  Awake craniotomy for glioblastoma in COVID-19-positive patients and delivering the standard of care: illustrative case.

Authors:  Reinier Alvarez; Rupesh Kotecha; Michael W McDermott; Vitaly Siomin
Journal:  J Neurosurg Case Lessons       Date:  2021-07-05

3.  Victoria (Australia) radiotherapy response to working through the first and second wave of COVID-19: Strategies and staffing.

Authors:  Kym Rykers; Mark Tacey; Jack Bowes; Kerryn Brown; Eva Yuen; Carlene Wilson; Richard Khor; Farshad Foroudi
Journal:  J Med Imaging Radiat Oncol       Date:  2021-04-27       Impact factor: 1.735

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.